Literature DB >> 16676657

Recovery from unusual attitudes: HUD vs. back-up display in a static F/A-18 simulator.

Samuel W Huber1.   

Abstract

OBJECTIVE: Spatial disorientation (SD) remains one of the most important causes of fatal fighter aircraft accidents. The aim of this study was to give a recommendation for the use of the head-up display (HUD) or back-up attitude directional indicator (ADI) in a state of spatial disorientation based on the respective performance in an unusual attitude recovery task.
METHODS: Seven fighter pilots joining a conversion course to the F/A-18 participated in this study. Flight time will be presented as range (and mean in parentheses). Total military flight experience of the subjects was 835-1759 h (1412 h). Flight time on the F/A-18 was 41-123 h (70 h). The study was performed in a fixed base F/A-18D Weapons Tactics Trainer. We tested the recovery from 11 unusual attitudes and analyzed decision time (DT), total recovery time (TRT), and error rates for the HUD or the back-up ADI.
RESULTS: We found no differences regarding either reaction times or error rates. For the HUD we found a DT (mean +/- SD) of 1.3 +/- 0.4 s, a TRT of 9.1 +/- 4.1 s, and an error rate of 29%. For the ADI the respective values were a DT of 1.4 +/- 0.4 s, a TRT of 8.3 +/- 3.8 s, and an error rate of 27%.
CONCLUSION: Unusual attitude recoveries are performed equally well using the HUD or the back-up ADI. Switching from one instrument to the other during recovery should be avoided since it would probably result in a loss of time without benefit.

Entities:  

Mesh:

Year:  2006        PMID: 16676657

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  1 in total

1.  The comparison of sensitivity of motion sickness between retinal degeneration fast mice and normal mice.

Authors:  Xiao-Cheng Wang; Zhao-Hui Shi; Ka Bian; Lei Zhang; Jun-Hui Xue; Guo-Qing Yang; Xue-Song Ge; Zuo-Ming Zhang
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2014-02-20       Impact factor: 1.836

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.